Slideshow

Early Diagnosis and Treatment of Lupus Essential in Racial/Ethnic Populations

A study published last month in Arthritis Care & Research shows that racial/ethnic minorities disproportionately have more severe cases of systemic lupus erythematosus (SLE). In this slideshow, we summarize the findings, but we'd like to know what you think. Email us your comments at areyes@mmhgroup.com.

A study published last month in Arthritis Care & Research shows that racial/ethnic minorities disproportionately have more severe cases of systemic lupus erythematosus (SLE). In this slideshow, we summarize the findings.Although there were a number of limitations associated with study, such as incomplete medical records in some cases, the analysis demonstrates some obvious differences in terms of the severity of disease and clinical manifestations among black, Hispanic and Asian patients. However, in factoring the findings, the authors accounted for risk factors including sex, age at diagnosis and disease duration.The authors of the study suggest some solutions, but the editors of Rheumatology Network woud like to know your thoughts as a healthcare provider. If you have recommendations for improving the  gap in healthcare outcomes described in this study, please share them with us by emailing the editor.See related article:  "Lupus is More Severe in Racial/Ethnic Minorities" REFERENCEManingding E, Dall’Era M, Turpin L, Murphy L, Yazdany J, Racial/Ethnic Differences in Prevalence of and Time to Onset of SLE Manifestations: The California Lupus Surveillance Project (CLSP), Arthritis Care & Research (2019), doi: 10.1002/acr.23887

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2024 MJH Life Sciences

All rights reserved.